Journal
CHEMMEDCHEM
Volume 11, Issue 21, Pages 2459-2465Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cmdc.201600408
Keywords
brain; central nervous system; thyroid hormones; thyromimetics
Categories
Funding
- US National Institutes of Health
Ask authors/readers for more resources
Sobetirome is one of the most studied thyroid hormone receptor (TR)-selective thyromimetics in the field due to its excellent selectivity and potency. A small structural changereplacing the 3,5-dimethyl groups of sobetirome with either chlorine or bromineproduces significantly more potent compounds, both invitro and invivo. These halogenated compounds induce transactivation of a TR-mediated cell-based reporter with an EC50 value comparable to that of T3, access the central nervous system (CNS) at levels similar to their parent, and activate an endogenous TR-regulated gene in the brain with an EC50 value roughly five-fold lower than that of sobetirome. Previous studies suggest that this apparent increase in affinity can be explained by halogen bonding between the ligand and a backbone carbonyl group in the receptor. This makes the new analogues potential candidates for treating CNS disorders that may respond favorably to thyroid-hormone-stimulated pathways.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available